Skip to main content
Log in

Protein binding and hepatic clearance: Studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

The influence of altered drug binding on the hepatic elimination of tolbutamide, a drug of low intrinsic clearance, and on the formation of its metabolite, hydroxytolbutamide, was examined under linear conditions at steady state in the isolated in situsingle-pass perfused rat liver preparation, with perfusate flow fixed at 15 ml/min. The fraction of tulbutamide unbound in the perfusate was varied (from 0.06 to 1.0) by either varying the perfusate concentration of albumin or using albumin of different animal species. The intrinsic clearance of tolbutamide varied fourfold between preparations (0.08–0.36 ml/min/g liver). Within each preparation the data were normalized to observations with a perfusate containing no protein. Both the extraction ratio (and clearance) of tolbutamide and the fraction of tulbutamide appearing as hydroxytolbutamide in effluent perfusate, a measure of hepatic metabolism, were directly proportional to the fraction of tolbutamide unbound in the perfusate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G. R. Wilkinson and D. G. Shand. Commentary. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).

    CAS  PubMed  Google Scholar 

  2. T. N. Tozer. Concepts basic to pharmacokinetics.Pharmacol. Ther. 12:109–132 (1981).

    Article  CAS  PubMed  Google Scholar 

  3. G. Levy and A. Yacobi. Effect of plasma protein binding on elimination of warfarin.J. Pharm. Sci. 63:805–706 (1974).

    Article  CAS  PubMed  Google Scholar 

  4. R. Gugler, D. W. Shoeman, D. H. Huffman, J. B. Cohlmia, and D. L. Azarnoff. Pharmacokinetics of drug in patients with the nephrotic syndrome.J. Clin. Invest. 55:1182–1186 (1975).

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. D. G. Shand, R. H. Cotham, and G. R. Wilkinson. Perfusion-limited effects of plasma drug binding in hepatic drug extraction.Life Sci. 19:125–130 (1976).

    Article  CAS  PubMed  Google Scholar 

  6. C-M. Lai and G. Levy. Comparative pharmacokinetics of coumarin anticoagulants. XXX. Relationship between total clearance and serum protein binding of dicoumarol in rats.J. Pharm. Sci. 66:1739–1741 (1977).

    Article  CAS  PubMed  Google Scholar 

  7. T. W. Guentert and S. Øie. Effect of plasma protein binding on quinidine kinetics in the rabbit.J. Pharmacol. Exp. Ther. 215:165–171 (1980).

    CAS  PubMed  Google Scholar 

  8. D. Trenk and E. Jähnchen. Effect of serum protein binding on pharmacokinetics and anticoagulant activity on phenprocoumon in rats.J. Pharmacokin. Biopharm. 8:177–191 (1980).

    Article  CAS  Google Scholar 

  9. R. C. Thomas and G. J. Ikeda. The metabolic fate of tolbutamide in man and in the rat.J. Med. Chem. 9:507–510 (1966).

    Article  CAS  PubMed  Google Scholar 

  10. J. Tagg, D. M. Yasula, M. Tanake, and C. Mitoma. Metabolic studies of tolbutamide in the rat.Biochem. Pharmacol. 16:143–153 (1967).

    Article  CAS  Google Scholar 

  11. K. S. Pang and M. Rowland. Hepatic clearance of drugs II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation.J. Pharmacokin. Biopharm. 5:655–680 (1977).

    Article  CAS  Google Scholar 

  12. S. B. Matin and M. Rowland. Simultaneous determination of tolbutamide and its metabolities in biological fluids.Anal. Lett. 6:865–876 (1973).

    Article  CAS  Google Scholar 

  13. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall. Protein measurements with the Folin regent.J. Biol. Chem. 193:193–275 (1951).

    Google Scholar 

  14. K. S. Pang and M. Rowland. Hepatic clearance of drugs I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J. Pharmacokin. Biopharm. 5:625–653 (1977).

    Article  CAS  Google Scholar 

  15. B. D. Ross.Perfusion Techniques in Biochemistry: A Laboratory Manual. Clarendon Press, Oxford, 1972.

    Google Scholar 

  16. J. Judis. Binding of sulfonylureas to serum proteins.J. Pharm. Sci. 61:89–93 (1972).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The authors wish to thank Ciba-Geigy (UK) for financial support.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schary, W.L., Rowland, M. Protein binding and hepatic clearance: Studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation. Journal of Pharmacokinetics and Biopharmaceutics 11, 225–243 (1983). https://doi.org/10.1007/BF01061866

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01061866

Key words

Navigation